JP2013521789A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013521789A5 JP2013521789A5 JP2012557522A JP2012557522A JP2013521789A5 JP 2013521789 A5 JP2013521789 A5 JP 2013521789A5 JP 2012557522 A JP2012557522 A JP 2012557522A JP 2012557522 A JP2012557522 A JP 2012557522A JP 2013521789 A5 JP2013521789 A5 JP 2013521789A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- antigen
- cell
- nucleic acid
- class
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31570410P | 2010-03-19 | 2010-03-19 | |
| GB1004551.6 | 2010-03-19 | ||
| GBGB1004551.6A GB201004551D0 (en) | 2010-03-19 | 2010-03-19 | NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| US61/315,704 | 2010-03-19 | ||
| PCT/EP2011/053863 WO2011113819A2 (en) | 2010-03-19 | 2011-03-15 | Novel immunotherapy against several tumors including gastrointestinal and gastric cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015165375A Division JP6103608B2 (ja) | 2010-03-19 | 2015-08-25 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013521789A JP2013521789A (ja) | 2013-06-13 |
| JP2013521789A5 true JP2013521789A5 (enExample) | 2014-04-10 |
| JP5891181B2 JP5891181B2 (ja) | 2016-03-22 |
Family
ID=42227949
Family Applications (10)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012557522A Expired - Fee Related JP5891181B2 (ja) | 2010-03-19 | 2011-03-15 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2015165375A Expired - Fee Related JP6103608B2 (ja) | 2010-03-19 | 2015-08-25 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2016154278A Expired - Fee Related JP6238258B2 (ja) | 2010-03-19 | 2016-08-05 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2017030876A Active JP6535040B2 (ja) | 2010-03-19 | 2017-02-22 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2017224260A Active JP6722644B2 (ja) | 2010-03-19 | 2017-11-22 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2020106497A Active JP7107586B2 (ja) | 2010-03-19 | 2020-06-19 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2020106500A Expired - Fee Related JP7034505B2 (ja) | 2010-03-19 | 2020-06-19 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2021017733A Expired - Fee Related JP7007504B2 (ja) | 2010-03-19 | 2021-02-05 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2022108874A Pending JP2022141743A (ja) | 2010-03-19 | 2022-07-06 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2024095464A Pending JP2024116331A (ja) | 2010-03-19 | 2024-06-12 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
Family Applications After (9)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015165375A Expired - Fee Related JP6103608B2 (ja) | 2010-03-19 | 2015-08-25 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2016154278A Expired - Fee Related JP6238258B2 (ja) | 2010-03-19 | 2016-08-05 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2017030876A Active JP6535040B2 (ja) | 2010-03-19 | 2017-02-22 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2017224260A Active JP6722644B2 (ja) | 2010-03-19 | 2017-11-22 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2020106497A Active JP7107586B2 (ja) | 2010-03-19 | 2020-06-19 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2020106500A Expired - Fee Related JP7034505B2 (ja) | 2010-03-19 | 2020-06-19 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2021017733A Expired - Fee Related JP7007504B2 (ja) | 2010-03-19 | 2021-02-05 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2022108874A Pending JP2022141743A (ja) | 2010-03-19 | 2022-07-06 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2024095464A Pending JP2024116331A (ja) | 2010-03-19 | 2024-06-12 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
Country Status (30)
| Country | Link |
|---|---|
| US (25) | US10064913B2 (enExample) |
| EP (9) | EP2845604B1 (enExample) |
| JP (10) | JP5891181B2 (enExample) |
| KR (13) | KR102324499B1 (enExample) |
| CN (8) | CN112409453A (enExample) |
| AU (1) | AU2011229199B2 (enExample) |
| BR (1) | BR112012023692B1 (enExample) |
| CA (5) | CA3076642C (enExample) |
| CY (5) | CY1119366T1 (enExample) |
| DK (6) | DK3363456T3 (enExample) |
| EA (8) | EA039357B1 (enExample) |
| ES (8) | ES2819861T3 (enExample) |
| GB (1) | GB201004551D0 (enExample) |
| HK (1) | HK1226297A1 (enExample) |
| HR (6) | HRP20150867T1 (enExample) |
| HU (6) | HUE027036T2 (enExample) |
| LT (5) | LT2923708T (enExample) |
| ME (3) | ME02229B (enExample) |
| MX (7) | MX382164B (enExample) |
| MY (2) | MY178651A (enExample) |
| NZ (7) | NZ711296A (enExample) |
| PH (4) | PH12021551360A1 (enExample) |
| PL (6) | PL2845604T3 (enExample) |
| PT (6) | PT3195873T (enExample) |
| RS (6) | RS60993B1 (enExample) |
| SG (4) | SG10201502093QA (enExample) |
| SI (6) | SI2923708T1 (enExample) |
| TW (9) | TWI621709B (enExample) |
| UA (3) | UA122047C2 (enExample) |
| WO (1) | WO2011113819A2 (enExample) |
Families Citing this family (101)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7604662B2 (en) | 2007-07-13 | 2009-10-20 | Boston Scientific Scimed, Inc. | Endoprostheses containing boride intermetallic phases |
| RS53782B1 (sr) | 2008-10-01 | 2015-06-30 | Immatics Biotechnologies Gmbh | Preparati tumor-asociranih peptida i odgovarajuća antikancerska vakcina za tretman glioblastoma (gbm) i drugih kancera |
| GB201004575D0 (en) * | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers |
| GB201004551D0 (en) | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| EP2400035A1 (en) * | 2010-06-28 | 2011-12-28 | Technische Universität München | Methods and compositions for diagnosing gastrointestinal stromal tumors |
| US9040046B2 (en) | 2011-01-31 | 2015-05-26 | Kai Xu | Sodium pump antibody agonists and methods of treating heart disease using the same |
| SG2014012363A (en) * | 2011-10-28 | 2014-09-26 | Oncotherapy Science Inc | Topk peptides and vaccines including the same |
| US10704021B2 (en) | 2012-03-15 | 2020-07-07 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
| ES2887580T3 (es) * | 2012-03-19 | 2021-12-23 | Stemline Therapeutics Inc | Métodos para el tratamiento y seguimiento del estado del cáncer |
| EP2849772A4 (en) | 2012-05-16 | 2016-03-02 | Stemline Therapeutics Inc | TUMOR VACCINES TREATED AGAINST CANCER STEM CELLS |
| WO2014010229A1 (en) * | 2012-07-10 | 2014-01-16 | Oncotherapy Science, Inc. | Cdca1 epitope peptides for th1 cells and vaccines containing the same |
| WO2014014518A1 (en) * | 2012-07-18 | 2014-01-23 | Dana-Farber Cancer Institute, Inc. | Methods for treating, preventing and predicting risk of developing breast cancer |
| JP6212249B2 (ja) * | 2012-08-08 | 2017-10-11 | 学校法人 京都産業大学 | カルシウムポンプ制御物質のスクリーニング方法、並びに、メラニン色素合成阻害物質のスクリーニング方法 |
| US9114157B2 (en) | 2012-08-30 | 2015-08-25 | The Board Of Trustees Of The Leland Stanford Junior University | Anti-tumor T cell immunity induced by high dose radiation |
| PT3456339T (pt) | 2013-08-05 | 2021-12-09 | Immatics Biotechnologies Gmbh | Nova imunoterapia contra vários tumores, tais como cancro do pulmão, incluindo cpnpc |
| TWI636065B (zh) * | 2013-08-05 | 2018-09-21 | 伊瑪提克斯生物科技有限公司 | 新穎肽類，細胞及其用於治療多種腫瘤的用途，其製造方法及包含其等之醫藥組成物 |
| EP2876442A1 (en) * | 2013-11-22 | 2015-05-27 | Institut de Cancérologie de l'Ouest | Olfactomedin-4, neudesin and desmoplakin as biomarkers of breast cancer |
| CA2935960C (en) | 2014-01-08 | 2023-01-10 | Bart Lipkens | Acoustophoresis device with dual acoustophoretic chamber |
| JP2017507950A (ja) | 2014-02-27 | 2017-03-23 | リセラ・コーポレイションＬｙｃｅｒａ Ｃｏｒｐｏｒａｔｉｏｎ | レチノイン酸受容体関連オーファン受容体ガンマのアゴニストを使用する養子細胞療法及び関連治療方法 |
| US10813984B2 (en) | 2014-04-24 | 2020-10-27 | Rhode Island Hospital | Aspartate-β-hydroxylase induces epitope-specific T cell responses in tumors |
| AU2015256190B2 (en) | 2014-05-05 | 2019-08-15 | Lycera Corporation | Tetrahydroquinoline sulfonamide and related compounds for use as agonists of rory and the treatment of disease |
| WO2015171558A2 (en) | 2014-05-05 | 2015-11-12 | Lycera Corporation | BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORγ AND THE TREATEMENT OF DISEASE |
| GB201408255D0 (en) * | 2014-05-09 | 2014-06-25 | Immatics Biotechnologies Gmbh | Novel immunotherapy against several tumours of the blood, such as acute myeloid leukemia (AML) |
| KR101644599B1 (ko) | 2014-10-14 | 2016-08-16 | 연세대학교 산학협력단 | 미토콘드리아 단백질 uqcrb 관련 질환 유전자발현 세포 구축 및 이를 활용한 uqcrb 기능조절 활성평가계 구축 |
| MA40737A (fr) | 2014-11-21 | 2017-07-04 | Memorial Sloan Kettering Cancer Center | Déterminants de la réponse d'un cancer à une immunothérapie par blocage de pd-1 |
| GB201423361D0 (en) * | 2014-12-30 | 2015-02-11 | Immatics Biotechnologies Gmbh | Method for the absolute Quantification of naturally processed HLA-Restricted cancer peptides |
| US11497767B2 (en) | 2015-02-18 | 2022-11-15 | Enlivex Therapeutics R&D Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| US11596652B2 (en) | 2015-02-18 | 2023-03-07 | Enlivex Therapeutics R&D Ltd | Early apoptotic cells for use in treating sepsis |
| AU2016221305B2 (en) | 2015-02-18 | 2021-05-27 | Enlivex Therapeutics Rdo Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| US11304976B2 (en) | 2015-02-18 | 2022-04-19 | Enlivex Therapeutics Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| US11000548B2 (en) | 2015-02-18 | 2021-05-11 | Enlivex Therapeutics Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| US11318163B2 (en) | 2015-02-18 | 2022-05-03 | Enlivex Therapeutics Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| GB201504502D0 (en) * | 2015-03-17 | 2015-04-29 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers |
| KR20240151873A (ko) | 2015-03-17 | 2024-10-18 | 이매틱스 바이오테크놀로지스 게엠베하 | 췌장암 및 기타 암에 대한 면역요법에서의 사용을 위한 펩티드 및 펩티드의 조합 |
| EP4140492A1 (en) | 2015-04-21 | 2023-03-01 | Enlivex Therapeutics Rdo Ltd | Therapeutic pooled blood apoptotic cell preparations and uses thereof |
| GB201507030D0 (en) | 2015-04-24 | 2015-06-10 | Immatics Biotechnologies Gmbh | Immunotherapy against lung cancers, in particular NSCLC |
| US11708572B2 (en) | 2015-04-29 | 2023-07-25 | Flodesign Sonics, Inc. | Acoustic cell separation techniques and processes |
| US11377651B2 (en) | 2016-10-19 | 2022-07-05 | Flodesign Sonics, Inc. | Cell therapy processes utilizing acoustophoresis |
| EP3292119A4 (en) | 2015-05-05 | 2018-10-03 | Lycera Corporation | DIHYDRO-2H-BENZO[b][1,4]OXAZINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATMENT OF DISEASE |
| NL2014935B1 (en) | 2015-06-08 | 2017-02-03 | Applied Immune Tech Ltd | T cell receptor like antibodies having fine specificity. |
| WO2016201225A1 (en) | 2015-06-11 | 2016-12-15 | Lycera Corporation | Aryl dihydro-2h-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of rory and the treatment of disease |
| GB201510771D0 (en) * | 2015-06-19 | 2015-08-05 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer |
| CA2989483A1 (en) * | 2015-06-19 | 2016-12-22 | Immatics Biotechnologies Gmbh | Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers |
| GB201511546D0 (en) | 2015-07-01 | 2015-08-12 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers |
| CN108026154B (zh) | 2015-07-01 | 2022-03-08 | 伊玛提克斯生物技术有限公司 | 用于卵巢癌和其他癌症免疫治疗的新型肽和肽组合物 |
| MY189596A (en) * | 2015-07-15 | 2022-02-18 | Immatics Biotechnologies Gmbh | A novel peptides for use in immunotherapy against epithelial ovarian cancer and other cancers |
| US20170136108A1 (en) * | 2015-08-28 | 2017-05-18 | Immatics Biotechnologies Gmbh | Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers |
| GB201515321D0 (en) | 2015-08-28 | 2015-10-14 | Immatics Biotechnologies Gmbh | Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers |
| TWI794761B (zh) | 2015-08-28 | 2023-03-01 | 德商英麥提克生物技術股份有限公司 | 用於多種癌症之免疫治療的新穎胜肽、胜肽的組合物及支架 |
| KR102601499B1 (ko) * | 2015-11-06 | 2023-11-13 | 연세대학교 산학협력단 | miRNA 발현 수준으로부터 UQCRB 관련 질병을 진단하는 방법 |
| GB201521746D0 (en) * | 2015-12-10 | 2016-01-27 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against CLL and other cancers |
| SG11201804957VA (en) | 2015-12-16 | 2018-07-30 | Gritstone Oncology Inc | Neoantigen identification, manufacture, and use |
| US11730761B2 (en) | 2016-02-18 | 2023-08-22 | Enlivex Therapeutics Rdo Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| GB201603568D0 (en) * | 2016-03-01 | 2016-04-13 | Immatics Biotechnologies Gmbh | Efficient treatment options including peptides and combination of peptide and cell based medicaments for use in immunotherapy against urinary bladder cancer |
| MA54832A (fr) * | 2016-03-01 | 2021-12-01 | Immatics Biotechnologies Gmbh | Peptides, combinaison de peptides et médicaments à base de cellules destinés à être utilisés en immunothérapie contre le cancer de la vessie et d'autres cancers |
| GB201603987D0 (en) * | 2016-03-08 | 2016-04-20 | Immatics Biotechnologies Gmbh | Uterine cancer treatments |
| GB201604458D0 (en) * | 2016-03-16 | 2016-04-27 | Immatics Biotechnologies Gmbh | Peptides and combination of peptides for use in immunotherapy against cancers |
| GB201604490D0 (en) * | 2016-03-16 | 2016-04-27 | Immatics Biotechnologies Gmbh | Peptides combination of peptides for use in immunotherapy against cancers |
| CR20200608A (es) | 2016-04-21 | 2021-01-20 | Immatics Biotechnologies Gmbh | INMUNOTERAPIA CONTRA EL MELANOMA Y OTROS TIPOS DE CÁNCER (Divisional 2018-0551) |
| PE20181897A1 (es) | 2016-04-21 | 2018-12-11 | Immatics Biotechnologies Gmbh | Inmunoterapia contra el melanoma y otros tipos de cancer |
| US11214789B2 (en) | 2016-05-03 | 2022-01-04 | Flodesign Sonics, Inc. | Concentration and washing of particles with acoustics |
| ZA201900664B (en) | 2016-08-17 | 2021-09-29 | Paul Ehrlich Strasse 15 Tuebingen 72076 Germany | T cell receptors and immune therapy using the same |
| DE102016115246C5 (de) | 2016-08-17 | 2018-12-20 | Immatics Biotechnologies Gmbh | Neue t-zellrezeptoren und deren verwendung in immuntherapie |
| PT3500593T (pt) * | 2016-08-17 | 2021-11-04 | Immatics Biotechnologies Gmbh | Recetores de células t e imunoterapia usando os mesmos |
| WO2018094569A1 (zh) * | 2016-11-22 | 2018-05-31 | 深圳华大基因研究院 | 多肽及其应用 |
| WO2018098715A1 (zh) * | 2016-11-30 | 2018-06-07 | 深圳华大基因研究院 | 多肽及其应用 |
| KR102379955B1 (ko) | 2016-12-08 | 2022-03-29 | 이매틱스 바이오테크놀로지스 게엠베하 | 짝짓기가 향상된 t 세포 수용체 |
| DE102016123893A1 (de) | 2016-12-08 | 2018-06-14 | Immatics Biotechnologies Gmbh | T-Zellrezeptoren mit verbesserter Bindung |
| WO2018189148A1 (en) * | 2017-04-10 | 2018-10-18 | Immatics Biotechnologies Gmbh | Peptides and combination thereof for use in the immunotherapy against cancers |
| CR20210159A (es) * | 2017-04-10 | 2021-05-21 | Immatics Biotechnologies Gmbh | Péptidos y combinaciones de los mismos para el uso en la inmunoterapia contra diversos tipos de cáncer (divisional de solicitud 2019-0508) |
| CR20200013A (es) | 2017-07-14 | 2020-03-11 | Immatics Biotechnologies Gmbh | Molécula de polipéptido con especificidad dual mejorada |
| DE102017115966A1 (de) | 2017-07-14 | 2019-01-17 | Immatics Biotechnologies Gmbh | Polypeptidmolekül mit verbesserter zweifacher Spezifität |
| EP4576103A3 (en) | 2017-10-10 | 2025-08-27 | Gritstone bio, Inc. | Neoantigen identification using hotspots |
| DE102017125888A1 (de) * | 2017-11-06 | 2019-05-23 | Immatics Biotechnologies Gmbh | Neue konstruierte T-Zell-Rezeptoren und deren Verwendung in Immuntherapie |
| FI3707159T3 (fi) | 2017-11-06 | 2023-04-18 | Immatics Biotechnologies Gmbh | Uusia muokattuja t-solureseptoreita ja niitä käyttävä immuuniterapia |
| KR20200090855A (ko) | 2017-11-22 | 2020-07-29 | 그릿스톤 온콜로지, 인코포레이티드 | 신생항원에 대한 접합 에피토프 제시 감소 |
| KR20220066413A (ko) | 2017-12-14 | 2022-05-24 | 프로디자인 소닉스, 인크. | 음향 트랜스듀서 구동기 및 제어기 |
| WO2019178081A1 (en) | 2018-03-12 | 2019-09-19 | The Children's Hospital Of Philadelphia | Methods and compositions for use of tumor self-antigens in adoptive immunotherapy |
| US12195769B2 (en) | 2018-06-19 | 2025-01-14 | Dsm Ip Assets B.V. | Lipolytic enzyme variants |
| WO2020081537A1 (en) * | 2018-10-16 | 2020-04-23 | Texas Tech University System | Method to express, purify, and biotinylate eukaryotic cell-derived major histocompatibility complexes |
| MA56036A (fr) | 2019-05-27 | 2022-04-06 | Immatics Us Inc | Vecteurs viraux et leur utilisation dans une thérapie cellulaire adoptive |
| DE102019114735A1 (de) * | 2019-06-02 | 2020-12-03 | PMCR GmbH | HLA-Tumorantigenpeptiden der Klasse I und II zur Behandlung von Mamma-/Brustkarzinomen |
| KR20220018006A (ko) | 2019-06-06 | 2022-02-14 | 이매틱스 바이오테크놀로지스 게엠베하 | 서열 유사 펩티드를 사용하는 계수기 선택에 의한 분류 |
| KR102397922B1 (ko) * | 2020-02-19 | 2022-05-13 | 서울대학교 산학협력단 | 신규한 종양-관련 항원 단백질 olfm4 및 이의 용도 |
| WO2022045768A1 (ko) | 2020-08-28 | 2022-03-03 | 계명대학교 산학협력단 | 당뇨병 치료제에 대한 약물반응성 예측용 마이크로 rna 바이오마커 및 이의 용도 |
| US20240024438A1 (en) * | 2020-11-19 | 2024-01-25 | Board Of Regents, The University Of Texas System | Methods and compositions comprising mhc class peptides |
| DE102021100038A1 (de) | 2020-12-31 | 2022-06-30 | Immatics US, Inc. | Modifizierte cd8-polypeptide, zusammensetzungen und verfahren zu deren verwendung |
| CR20230295A (es) | 2020-12-31 | 2023-07-27 | Immatics Us Inc | Polipéptidos cd8, composiciones y métodos de uso de estos |
| IL308258A (en) | 2021-05-05 | 2024-01-01 | Immatics Biotechnologies Gmbh | Bma031 antigen binding polypeptides |
| CN114732898B (zh) * | 2022-04-01 | 2023-05-09 | 中国人民解放军军事科学院军事医学研究院 | 一种CpG佐剂与抗原定点共价结合方法 |
| IL316515A (en) | 2022-04-28 | 2024-12-01 | Immatics Us Inc | Membrane-bound IL15 CD8 proteins, cells, compositions and methods for their use |
| EP4514821A1 (en) | 2022-04-28 | 2025-03-05 | Immatics US, Inc. | Il-12 polypeptides, il-15 polypeptides, il-18 polypeptides, cd8 polypeptides, compositions, and methods of using thereof |
| WO2023212691A1 (en) | 2022-04-28 | 2023-11-02 | Immatics US, Inc. | DOMINANT NEGATIVE TGFβ RECEPTOR POLYPEPTIDES, CD8 POLYPEPTIDES, CELLS, COMPOSITIONS, AND METHODS OF USING THEREOF |
| WO2023215825A1 (en) | 2022-05-05 | 2023-11-09 | Immatics US, Inc. | Methods for improving t cell efficacy |
| WO2024072954A1 (en) * | 2022-09-29 | 2024-04-04 | Jerome Canady Research Institute for Advanced Biological and Technological Sciences | Cold atmopsheric plasma treated pan-cancer epitope peptide within the collagen type vi a-3 (col6a3) protein as cancer vaccine |
| WO2024077071A2 (en) * | 2022-10-05 | 2024-04-11 | The Johns Hopkins University | Nanoparticles for delivery of immunoregulatory materials to t cells |
| WO2024168055A1 (en) * | 2023-02-08 | 2024-08-15 | Navigen, Inc. | Tnf-alpha binding agents and methods of using the same |
| CN116102468B (zh) * | 2023-02-22 | 2024-07-09 | 中国科学技术大学 | 靶向人脂质运载蛋白2的先导化合物或其药学上可接受的盐及其制备方法与应用 |
| WO2024225764A1 (ko) * | 2023-04-26 | 2024-10-31 | 한국과학기술원 | 섬유아세포 활성화 단백질의 면역우세 에피토프 펩타이드 및 이의 용도 |
| WO2025096649A1 (en) | 2023-11-01 | 2025-05-08 | Immatics US, Inc. | Membrane-bound il-15, cd8 polypeptides, cells, compositions, and methods of using thereof |
| CN119679951A (zh) * | 2025-02-11 | 2025-03-25 | 安徽医科大学 | E3泛素连接酶syvn1的抑制物质在制备胃癌治疗药物中的应用 |
Family Cites Families (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4440859A (en) | 1977-05-27 | 1984-04-03 | The Regents Of The University Of California | Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms |
| US4704362A (en) | 1977-11-08 | 1987-11-03 | Genentech, Inc. | Recombinant cloning vehicle microbial polypeptide expression |
| IE53176B1 (en) | 1978-12-22 | 1988-08-17 | Biogen Nv | Recombinant dna molecules and their method of production |
| US4530901A (en) | 1980-01-08 | 1985-07-23 | Biogen N.V. | Recombinant DNA molecules and their use in producing human interferon-like polypeptides |
| US4342566A (en) | 1980-02-22 | 1982-08-03 | Scripps Clinic & Research Foundation | Solid phase anti-C3 assay for detection of immune complexes |
| US4678751A (en) | 1981-09-25 | 1987-07-07 | Genentech, Inc. | Hybrid human leukocyte interferons |
| US4766075A (en) | 1982-07-14 | 1988-08-23 | Genentech, Inc. | Human tissue plasminogen activator |
| US4582800A (en) | 1982-07-12 | 1986-04-15 | Hoffmann-La Roche Inc. | Novel vectors and method for controlling interferon expression |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4757006A (en) | 1983-10-28 | 1988-07-12 | Genetics Institute, Inc. | Human factor VIII:C gene and recombinant methods for production |
| US4677063A (en) | 1985-05-02 | 1987-06-30 | Cetus Corporation | Human tumor necrosis factor |
| US4810648A (en) | 1986-01-08 | 1989-03-07 | Rhone Poulenc Agrochimie | Haloarylnitrile degrading gene, its use, and cells containing the gene |
| US4897445A (en) | 1986-06-27 | 1990-01-30 | The Administrators Of The Tulane Educational Fund | Method for synthesizing a peptide containing a non-peptide bond |
| AU6852594A (en) | 1993-06-03 | 1995-01-03 | Therapeutic Antibodies Inc. | Production of antibody fragments |
| AUPM322393A0 (en) | 1993-12-24 | 1994-01-27 | Austin Research Institute, The | Mucin carbohydrate compounds and their use in immunotherapy |
| US6805861B2 (en) | 1996-01-17 | 2004-10-19 | Imperial College Innovations Limited | Immunotherapy using cytotoxic T lymphocytes (CTL) |
| US5849589A (en) | 1996-03-11 | 1998-12-15 | Duke University | Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells |
| US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| US8299321B2 (en) | 1998-06-16 | 2012-10-30 | Monsanto Technology Llc | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
| JP2002525382A (ja) * | 1998-09-25 | 2002-08-13 | ザ チルドレンズ メディカル センター コーポレイション | プロテインキナーゼの活性を選択的に調節するショートペプチド |
| AU3395900A (en) * | 1999-03-12 | 2000-10-04 | Human Genome Sciences, Inc. | Human lung cancer associated gene sequences and polypeptides |
| AU2087401A (en) * | 1999-12-10 | 2001-06-18 | Epimmune, Inc. | Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions |
| JP4310104B2 (ja) | 2002-09-28 | 2009-08-05 | 英俊 猪子 | マイクロサテライト遺伝多型マーカを用いる遺伝子のマッピング方法 |
| US20110131679A2 (en) | 2000-04-19 | 2011-06-02 | Thomas La Rosa | Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement |
| US20070067865A1 (en) | 2000-09-05 | 2007-03-22 | Kovalic David K | Annotated plant genes |
| WO2002020036A1 (de) * | 2000-09-06 | 2002-03-14 | Mueller Friederike | Arzneimittel mit einer für das rna-bindende koc-protein kodierenden dna-sequenz, einem koc-protein oder einer dna-sequenz des koc-promotors |
| EP1330543A4 (en) | 2000-10-02 | 2006-03-29 | Bayer Ag | IN CANCER TISSUE, EXPRESSED NUCLEIC ACID SEQUENCES DIFFERENTIATE |
| US6673549B1 (en) * | 2000-10-12 | 2004-01-06 | Incyte Corporation | Genes expressed in C3A liver cell cultures treated with steroids |
| USH2191H1 (en) | 2000-10-24 | 2007-06-05 | Snp Consortium | Identification and mapping of single nucleotide polymorphisms in the human genome |
| EP1538163A3 (en) * | 2000-11-01 | 2005-06-15 | Insight Biotechnology Limited | Phosphorylated Amyloid-Beta 1-43 Protein and its use in the treatment of Alzheimer's disease |
| US7919467B2 (en) * | 2000-12-04 | 2011-04-05 | Immunotope, Inc. | Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| US20040236091A1 (en) * | 2001-03-28 | 2004-11-25 | Chicz Roman M. | Translational profiling |
| AU2002303219A1 (en) * | 2001-03-30 | 2002-10-15 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of cancer |
| US20040025202A1 (en) | 2002-03-15 | 2004-02-05 | Laurie Cathy C. | Nucleic acid molecules associated with oil in plants |
| DE10225139A1 (de) * | 2002-05-29 | 2004-02-26 | Immatics Biotechnologies Gmbh | Verfahren zur Identifizierung von immunreaktiven Peptiden |
| US20050221350A1 (en) * | 2002-05-29 | 2005-10-06 | Toni Weinschenk | Method for identifying immunoreactive peptides |
| WO2004014867A2 (en) * | 2002-08-13 | 2004-02-19 | Warner-Lambert Company Llc | Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
| US20060188889A1 (en) * | 2003-11-04 | 2006-08-24 | Christopher Burgess | Use of differentially expressed nucleic acid sequences as biomarkers for cancer |
| WO2005049806A2 (en) * | 2003-03-14 | 2005-06-02 | Nuvelo, Inc. | Novel nucleic acids and polypeptides |
| US20070037204A1 (en) * | 2003-08-08 | 2007-02-15 | Hiroyuki ABURANTAI | Gene overexpressed in cancer |
| WO2005019258A2 (en) * | 2003-08-11 | 2005-03-03 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| US20070054278A1 (en) | 2003-11-18 | 2007-03-08 | Applera Corporation | Polymorphisms in nucleic acid molecules encoding human enzyme proteins, methods of detection and uses thereof |
| AU2005207882A1 (en) * | 2004-01-27 | 2005-08-11 | Compugen Usa, Inc. | Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer |
| EP1568383A3 (en) | 2004-02-27 | 2005-11-16 | Antisense Pharma GmbH | Use of an oligonucleotide or its active derivative for the preparation of a pharmaceutical composition for inhibiting the formation of metastases in cancer treatment |
| US20070039069A1 (en) | 2004-03-22 | 2007-02-15 | Rogers James A | Nucleic acid molecules associated with oil in plants |
| TW200600785A (en) | 2004-03-23 | 2006-01-01 | Oncotherapy Science Inc | Method for diagnosing non-small cell lung cancer |
| US8435507B2 (en) * | 2004-08-19 | 2013-05-07 | University Of Maryland | Prostate-specific antigen-derived MHC class II restricted peptides and their use in vaccines to treat or prevent prostate cancer |
| AT501014A1 (de) * | 2004-08-19 | 2006-05-15 | Kury & Zeillinger Oeg | Verfahren und kit zur diagnose einer krebserkrankung, verfahren zum feststellen des ansprechens eines patienten auf die behandlung einer krebserkrankung, therapeutikum zur prophylaxe oder behandlung einer krebserkrankung |
| WO2007005635A2 (en) * | 2005-07-01 | 2007-01-11 | Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Mitotic spindle protein aspm as a diagnostic marker for neoplasia and uses therefor |
| PL1760089T3 (pl) * | 2005-09-05 | 2010-03-31 | Immatics Biotechnologies Gmbh | Peptydy towarzyszące nowotworom, wiążące się z cząsteczkami klasy I i II antygenów ludzkich leukocytów (HLA) i związana z nimi szczepionka przeciwnowotworowa |
| ATE461215T1 (de) * | 2005-09-05 | 2010-04-15 | Immatics Biotechnologies Gmbh | Tumor-assoziierte peptide, welche an unterschiedliche menschliche leukozytenantigene der klasse ii binden |
| GB0521958D0 (en) | 2005-10-27 | 2005-12-07 | Ares Trading Sa | vWFA, collagen and kunitz domain containing protein |
| DE102005052384B4 (de) * | 2005-10-31 | 2009-09-24 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Verfahren zur Erkennung, Markierung und Behandlung von epithelialen Lungentumorzellen sowie Mittel zur Durchführung des Verfahrens |
| US20080058272A1 (en) * | 2006-08-29 | 2008-03-06 | Juergen Becker | Nonamer Peptides for Cancer Treatment |
| US20090004213A1 (en) | 2007-03-26 | 2009-01-01 | Immatics Biotechnologies Gmbh | Combination therapy using active immunotherapy |
| CN103360466B (zh) * | 2007-07-27 | 2016-08-03 | 伊玛提克斯生物技术有限公司 | 抗肿瘤相关肽及相关抗癌疫苗组合物 |
| ES2553207T3 (es) * | 2007-07-27 | 2015-12-07 | Immatics Biotechnologies Gmbh | Nuevo epítopo inmunogénico para inmunoterapia |
| US7892770B2 (en) * | 2007-08-24 | 2011-02-22 | Van Andel Research Institute | Monoclonal antibody which binds cMet (HGFR) in formalin-fixed and paraffin-embedded tissues and related methods |
| NZ562237A (en) | 2007-10-05 | 2011-02-25 | Pacific Edge Biotechnology Ltd | Proliferation signature and prognosis for gastrointestinal cancer |
| WO2009075883A2 (en) * | 2007-12-12 | 2009-06-18 | University Of Georgia Research Foundation, Inc. | Glycoprotein cancer biomarker |
| UA104572C2 (ru) * | 2008-04-24 | 2014-02-25 | Имматикс Байотекнолоджиз Гмбх | Новые композиции опухолеассоциированных пептидов, которые связываются с молекулами i или ii класса лейкоцитарного антигена человека (hla) для разработки вакцин |
| KR101184869B1 (ko) * | 2008-04-24 | 2012-09-20 | 이매틱스 바이오테크놀로지스 게엠베하 | 백신을 위한 인간 조직 적합성 항원(ｈｌａ) 종류 ｉ 또는 ｉｉ 분자에 결합하는 종양 관련 펩티드의 신규한 제형 |
| SI2113253T1 (sl) | 2008-04-30 | 2010-06-30 | Immatics Biotechnologies Gmbh | Nove formulacije s tumorjem povezanih peptidov ki se vežejo na molekule humanega levkocitnega antigena HLA razreda I ali II za cepiva |
| US8133686B2 (en) * | 2008-05-15 | 2012-03-13 | Van Andel Research Institute | IL-8 as a biomarker for sunitinib resistance |
| TWI526219B (zh) * | 2008-06-19 | 2016-03-21 | 腫瘤療法 科學股份有限公司 | Ｃｄｃａ１抗原決定位胜肽及含此胜肽的疫苗 |
| WO2010037395A2 (en) * | 2008-10-01 | 2010-04-08 | Dako Denmark A/S | Mhc multimers in cancer vaccines and immune monitoring |
| RS53782B1 (sr) | 2008-10-01 | 2015-06-30 | Immatics Biotechnologies Gmbh | Preparati tumor-asociranih peptida i odgovarajuća antikancerska vakcina za tretman glioblastoma (gbm) i drugih kancera |
| GB201019331D0 (en) * | 2010-03-19 | 2010-12-29 | Immatics Biotechnologies Gmbh | Methods for the diagnosis and treatment of cancer based on AVL9 |
| GB201004551D0 (en) | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| GB201004575D0 (en) | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers |
| GB201006360D0 (en) * | 2010-04-16 | 2010-06-02 | Immatics Biotechnologies Gmbh | Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development |
| GB201015765D0 (en) * | 2010-09-21 | 2010-10-27 | Immatics Biotechnologies Gmbh | Use of myeloid cell biomarkers for the diagnosis of cancer |
| GB201021289D0 (en) * | 2010-12-15 | 2011-01-26 | Immatics Biotechnologies Gmbh | Novel biomarkers for a prediction of the outcome of an immunotherapy against cancer |
-
2010
- 2010-03-19 GB GBGB1004551.6A patent/GB201004551D0/en not_active Ceased
-
2011
- 2011-03-15 WO PCT/EP2011/053863 patent/WO2011113819A2/en not_active Ceased
- 2011-03-15 KR KR1020207026532A patent/KR102324499B1/ko active Active
- 2011-03-15 DK DK18156634.0T patent/DK3363456T3/da active
- 2011-03-15 RS RS20201304A patent/RS60993B1/sr unknown
- 2011-03-15 PL PL14184348T patent/PL2845604T3/pl unknown
- 2011-03-15 PL PL15154344T patent/PL2923708T3/pl unknown
- 2011-03-15 ES ES17203096T patent/ES2819861T3/es active Active
- 2011-03-15 CN CN202011080378.9A patent/CN112409453A/zh active Pending
- 2011-03-15 DK DK17157398.3T patent/DK3195873T3/da active
- 2011-03-15 CN CN202011079539.2A patent/CN112409451B/zh active Active
- 2011-03-15 PH PH1/2021/551360A patent/PH12021551360A1/en unknown
- 2011-03-15 HU HUE11711292A patent/HUE027036T2/en unknown
- 2011-03-15 KR KR1020227004088A patent/KR20220025133A/ko not_active Ceased
- 2011-03-15 SI SI201131293T patent/SI2923708T1/sl unknown
- 2011-03-15 EA EA201690511A patent/EA039357B1/ru unknown
- 2011-03-15 LT LTEP15154344.4T patent/LT2923708T/lt unknown
- 2011-03-15 DK DK15154344.4T patent/DK2923708T3/en active
- 2011-03-15 LT LTEP18156634.0T patent/LT3363456T/lt unknown
- 2011-03-15 KR KR1020237031847A patent/KR20230141886A/ko active Pending
- 2011-03-15 KR KR1020167023720A patent/KR101826460B1/ko active Active
- 2011-03-15 HU HUE17203096A patent/HUE050376T2/hu unknown
- 2011-03-15 EA EA202091251A patent/EA202091251A3/ru unknown
- 2011-03-15 CA CA3076642A patent/CA3076642C/en active Active
- 2011-03-15 UA UAA201512437A patent/UA122047C2/uk unknown
- 2011-03-15 PT PT171573983T patent/PT3195873T/pt unknown
- 2011-03-15 KR KR1020207026527A patent/KR102388761B1/ko active Active
- 2011-03-15 RS RS20150530A patent/RS54182B1/sr unknown
- 2011-03-15 PL PL18156634T patent/PL3363456T3/pl unknown
- 2011-03-15 CN CN202011079575.9A patent/CN112409452A/zh active Pending
- 2011-03-15 HU HUE18156634A patent/HUE051478T2/hu unknown
- 2011-03-15 NZ NZ711296A patent/NZ711296A/en not_active IP Right Cessation
- 2011-03-15 BR BR112012023692A patent/BR112012023692B1/pt active IP Right Grant
- 2011-03-15 NZ NZ769427A patent/NZ769427A/en not_active IP Right Cessation
- 2011-03-15 SI SI201130546T patent/SI2547354T1/sl unknown
- 2011-03-15 CA CA2986969A patent/CA2986969C/en active Active
- 2011-03-15 KR KR1020217004319A patent/KR102361467B1/ko not_active Expired - Fee Related
- 2011-03-15 ES ES15154344.4T patent/ES2642562T3/es active Active
- 2011-03-15 SI SI201131913T patent/SI3329933T1/sl unknown
- 2011-03-15 ME MEP-2015-122A patent/ME02229B/me unknown
- 2011-03-15 CA CA3206214A patent/CA3206214A1/en active Pending
- 2011-03-15 PL PL11711292T patent/PL2547354T3/pl unknown
- 2011-03-15 KR KR1020207026525A patent/KR102324498B1/ko not_active Expired - Fee Related
- 2011-03-15 SI SI201131927T patent/SI3363456T1/sl unknown
- 2011-03-15 LT LT17157398T patent/LT3195873T/lt unknown
- 2011-03-15 RS RS20201054A patent/RS60765B1/sr unknown
- 2011-03-15 LT LTEP14184348.2T patent/LT2845604T/lt unknown
- 2011-03-15 SG SG10201502093QA patent/SG10201502093QA/en unknown
- 2011-03-15 EP EP14184348.2A patent/EP2845604B1/en active Active
- 2011-03-15 CA CA2789857A patent/CA2789857C/en active Active
- 2011-03-15 JP JP2012557522A patent/JP5891181B2/ja not_active Expired - Fee Related
- 2011-03-15 EA EA202091250A patent/EA202091250A3/ru unknown
- 2011-03-15 HR HRP20150867TT patent/HRP20150867T1/hr unknown
- 2011-03-15 NZ NZ708205A patent/NZ708205A/en not_active IP Right Cessation
- 2011-03-15 EA EA202091241A patent/EA202091241A3/ru unknown
- 2011-03-15 PT PT181566340T patent/PT3363456T/pt unknown
- 2011-03-15 SI SI201131804T patent/SI3195873T1/sl unknown
- 2011-03-15 HU HUE14184348A patent/HUE032402T2/en unknown
- 2011-03-15 EA EA201201306A patent/EA024497B1/ru unknown
- 2011-03-15 KR KR1020127027196A patent/KR101656913B1/ko active Active
- 2011-03-15 CN CN201180014644.0A patent/CN102905721B/zh active Active
- 2011-03-15 EP EP17157398.3A patent/EP3195873B1/en active Active
- 2011-03-15 ES ES17157398T patent/ES2753206T3/es active Active
- 2011-03-15 PT PT151543444T patent/PT2923708T/pt unknown
- 2011-03-15 ES ES18156634T patent/ES2829375T3/es active Active
- 2011-03-15 RS RS20170553A patent/RS56070B1/sr unknown
- 2011-03-15 KR KR1020197005246A patent/KR20190033577A/ko not_active Ceased
- 2011-03-15 CN CN201510354965.5A patent/CN105001339B/zh active Active
- 2011-03-15 PT PT117112920T patent/PT2547354E/pt unknown
- 2011-03-15 HU HUE15154344A patent/HUE033682T2/en unknown
- 2011-03-15 ES ES20179380T patent/ES2992110T3/es active Active
- 2011-03-15 EP EP18156634.0A patent/EP3363456B1/en active Active
- 2011-03-15 RS RS20191340A patent/RS59554B1/sr unknown
- 2011-03-15 US US13/635,896 patent/US10064913B2/en active Active
- 2011-03-15 MX MX2017015735A patent/MX382164B/es unknown
- 2011-03-15 EA EA201792409A patent/EA037019B1/ru unknown
- 2011-03-15 MX MX2012010813A patent/MX2012010813A/es active IP Right Grant
- 2011-03-15 KR KR1020187002782A patent/KR20180014848A/ko not_active Ceased
- 2011-03-15 EA EA202091242A patent/EA202091242A3/ru unknown
- 2011-03-15 ES ES11711292.0T patent/ES2544529T3/es active Active
- 2011-03-15 CA CA2936642A patent/CA2936642C/en active Active
- 2011-03-15 SG SG10201710446PA patent/SG10201710446PA/en unknown
- 2011-03-15 EP EP20179386.6A patent/EP3738606B1/en active Active
- 2011-03-15 NZ NZ769435A patent/NZ769435A/en not_active IP Right Cessation
- 2011-03-15 ME MEP-2017-87A patent/ME02692B/me unknown
- 2011-03-15 MY MYPI2012700609A patent/MY178651A/en unknown
- 2011-03-15 EP EP15154344.4A patent/EP2923708B1/en active Active
- 2011-03-15 PH PH1/2012/501821A patent/PH12012501821A1/en unknown
- 2011-03-15 NZ NZ72784111A patent/NZ727841A/en not_active IP Right Cessation
- 2011-03-15 SG SG10201606771SA patent/SG10201606771SA/en unknown
- 2011-03-15 LT LTEP17203096.7T patent/LT3329933T/lt unknown
- 2011-03-15 EP EP11711292.0A patent/EP2547354B1/en active Active
- 2011-03-15 DK DK11711292.0T patent/DK2547354T3/da active
- 2011-03-15 ES ES14184348.2T patent/ES2626798T3/es active Active
- 2011-03-15 SG SG2012065173A patent/SG183880A1/en unknown
- 2011-03-15 CN CN201810105798.4A patent/CN108456242A/zh active Pending
- 2011-03-15 AU AU2011229199A patent/AU2011229199B2/en not_active Ceased
- 2011-03-15 PT PT172030967T patent/PT3329933T/pt unknown
- 2011-03-15 NZ NZ601438A patent/NZ601438A/en not_active IP Right Cessation
- 2011-03-15 ES ES20179386T patent/ES2993310T3/es active Active
- 2011-03-15 DK DK17203096.7T patent/DK3329933T3/da active
- 2011-03-15 EA EA202091233A patent/EA202091233A3/ru unknown
- 2011-03-15 PT PT141843482T patent/PT2845604T/pt unknown
- 2011-03-15 EP EP20179380.9A patent/EP3753570B1/en active Active
- 2011-03-15 EP EP16156192.3A patent/EP3058947A3/en not_active Withdrawn
- 2011-03-15 HU HUE17157398A patent/HUE045757T2/hu unknown
- 2011-03-15 RS RS20170980A patent/RS56612B1/sr unknown
- 2011-03-15 KR KR1020217004318A patent/KR102329791B1/ko active Active
- 2011-03-15 DK DK14184348.2T patent/DK2845604T3/da active
- 2011-03-15 KR KR1020207026530A patent/KR102324500B1/ko active Active
- 2011-03-15 KR KR1020207026524A patent/KR102388577B1/ko active Active
- 2011-03-15 PL PL17157398T patent/PL3195873T3/pl unknown
- 2011-03-15 CN CN202011080388.2A patent/CN112430255A/zh active Pending
- 2011-03-15 UA UAA201209114A patent/UA111711C2/uk unknown
- 2011-03-15 NZ NZ627877A patent/NZ627877A/en not_active IP Right Cessation
- 2011-03-15 UA UAA201801266A patent/UA126787C2/uk unknown
- 2011-03-15 EP EP17203096.7A patent/EP3329933B1/en active Active
- 2011-03-15 ME MEP-2019-287A patent/ME03569B/me unknown
- 2011-03-15 PL PL17203096T patent/PL3329933T3/pl unknown
- 2011-03-15 CN CN202011079527.XA patent/CN112457390A/zh active Pending
- 2011-03-15 SI SI201131182A patent/SI2845604T1/sl unknown
- 2011-03-18 TW TW104113109A patent/TWI621709B/zh active
- 2011-03-18 TW TW109130852A patent/TWI766362B/zh active
- 2011-03-18 TW TW108144354A patent/TWI715332B/zh not_active IP Right Cessation
- 2011-03-18 TW TW109130850A patent/TWI768461B/zh not_active IP Right Cessation
- 2011-03-18 TW TW100109429A patent/TWI486445B/zh not_active IP Right Cessation
- 2011-03-18 US US13/051,665 patent/US9101585B2/en active Active
- 2011-03-18 TW TW111118219A patent/TW202300509A/zh unknown
- 2011-03-18 TW TW107110964A patent/TWI681967B/zh not_active IP Right Cessation
- 2011-03-18 TW TW109130851A patent/TWI766361B/zh not_active IP Right Cessation
- 2011-03-18 TW TW106141450A patent/TWI659967B/zh not_active IP Right Cessation
-
2012
- 2012-09-06 MY MYPI2016002170A patent/MY197710A/en unknown
- 2012-09-19 MX MX2015001606A patent/MX355074B/es unknown
- 2012-09-19 MX MX2020011672A patent/MX2020011672A/es unknown
- 2012-09-19 MX MX2020011674A patent/MX2020011674A/es unknown
- 2012-09-19 MX MX2020011673A patent/MX2020011673A/es unknown
- 2012-09-19 MX MX2020011675A patent/MX2020011675A/es unknown
-
2013
- 2013-07-10 HK HK16114573.8A patent/HK1226297A1/en unknown
-
2015
- 2015-02-06 US US14/615,539 patent/US9717774B2/en active Active
- 2015-08-25 JP JP2015165375A patent/JP6103608B2/ja not_active Expired - Fee Related
-
2016
- 2016-05-23 PH PH12016500949A patent/PH12016500949B1/en unknown
- 2016-08-05 JP JP2016154278A patent/JP6238258B2/ja not_active Expired - Fee Related
-
2017
- 2017-02-22 JP JP2017030876A patent/JP6535040B2/ja active Active
- 2017-05-04 CY CY20171100486T patent/CY1119366T1/el unknown
- 2017-05-12 HR HRP20170718TT patent/HRP20170718T1/hr unknown
- 2017-06-28 US US15/636,486 patent/US20170304399A1/en not_active Abandoned
- 2017-06-29 US US15/636,958 patent/US9895415B2/en active Active
- 2017-06-30 US US15/639,310 patent/US9993523B2/en active Active
- 2017-06-30 US US15/639,506 patent/US10357540B2/en active Active
- 2017-10-06 HR HRP20171504TT patent/HRP20171504T1/hr unknown
- 2017-10-10 CY CY20171101050T patent/CY1119739T1/el unknown
- 2017-11-22 JP JP2017224260A patent/JP6722644B2/ja active Active
-
2019
- 2019-05-22 US US16/419,818 patent/US10420816B1/en active Active
- 2019-07-03 US US16/502,268 patent/US10478471B2/en active Active
- 2019-09-24 PH PH12019502194A patent/PH12019502194A1/en unknown
- 2019-10-14 HR HRP20191859TT patent/HRP20191859T1/hr unknown
- 2019-10-18 CY CY20191101092T patent/CY1122235T1/el unknown
- 2019-12-13 US US16/714,098 patent/US10905741B2/en not_active Expired - Fee Related
-
2020
- 2020-06-05 US US16/894,212 patent/US10933118B2/en active Active
- 2020-06-05 US US16/894,186 patent/US10898546B2/en active Active
- 2020-06-19 JP JP2020106497A patent/JP7107586B2/ja active Active
- 2020-06-19 JP JP2020106500A patent/JP7034505B2/ja not_active Expired - Fee Related
- 2020-09-14 HR HRP20201467TT patent/HRP20201467T1/hr unknown
- 2020-09-22 CY CY20201100894T patent/CY1123447T1/el unknown
- 2020-11-02 HR HRP20201770TT patent/HRP20201770T1/hr unknown
- 2020-11-04 CY CY20201101040T patent/CY1123762T1/el unknown
-
2021
- 2021-01-28 US US17/161,253 patent/US11077171B2/en active Active
- 2021-02-05 JP JP2021017733A patent/JP7007504B2/ja not_active Expired - Fee Related
- 2021-04-23 US US17/238,943 patent/US11850274B2/en active Active
- 2021-05-14 US US17/320,782 patent/US11883462B2/en active Active
- 2021-05-21 US US17/327,116 patent/US11839643B2/en active Active
- 2021-06-25 US US17/358,676 patent/US11969455B2/en active Active
- 2021-07-23 US US17/383,855 patent/US11957730B2/en active Active
- 2021-07-23 US US17/383,892 patent/US11975042B2/en active Active
- 2021-09-24 US US17/484,568 patent/US20220008506A1/en not_active Abandoned
- 2021-09-24 US US17/484,703 patent/US11273200B2/en active Active
- 2021-10-01 US US17/492,219 patent/US11298404B2/en active Active
- 2021-10-01 US US17/491,742 patent/US12064465B2/en active Active
-
2022
- 2022-04-29 US US17/733,260 patent/US11648292B2/en active Active
- 2022-07-06 JP JP2022108874A patent/JP2022141743A/ja active Pending
-
2024
- 2024-06-12 JP JP2024095464A patent/JP2024116331A/ja active Pending
- 2024-10-18 US US18/920,658 patent/US20250049886A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013521789A5 (enExample) | ||
| JP2010534463A5 (enExample) | ||
| HRP20170718T1 (hr) | Nova imunoterapija protiv nekoliko tumora uključujući gastrointestinalni i gastrični karcinom | |
| JP2009506762A5 (enExample) | ||
| JP2020182458A5 (enExample) | ||
| JP2018509135A5 (enExample) | ||
| JP2020198875A5 (enExample) | ||
| JP2020191862A5 (enExample) | ||
| HRP20201228T1 (hr) | Nova imunoterapija protiv nekoliko tumora, uključujući tumore neurona i mozga | |
| JP2017525336A5 (enExample) | ||
| HRP20100128T1 (hr) | Tumoru pridruženi peptid koji se slobodno veže na molekule humanog leukocitnog antigena (hla) klase ii | |
| RU2020113032A (ru) | Новые пептиды и комбинации пептидов для применения в иммунотерапии рака легких, в том числе немелкоклеточного рака легких (нмрл) и других видов рака | |
| JP2018536383A5 (enExample) | ||
| JP2018532382A5 (enExample) | ||
| JP7164598B2 (ja) | トランスジェニックマクロファージ、キメラ抗原受容体、及び関連する方法 | |
| HRP20192262T1 (hr) | Nova imunoterapija protiv nekoliko tumora, kao što su rak pluća, uključujući mikrocelularni karcinom pluća (nsclc) | |
| JP2017524337A5 (enExample) | ||
| JP2018511321A5 (enExample) | ||
| JP2019510465A5 (enExample) | ||
| JP2018510628A5 (enExample) | ||
| CN115443124A (zh) | 人工突触 | |
| KR20220103928A (ko) | 시험관 내 활성화 및 연쇄 살해 t 세포 집단의 확장 및 종양 세포 사멸 세포로 암 환자의 수동 면역화를 위한 조성물 및 방법 | |
| JP2015524788A5 (enExample) | ||
| CN114072166A (zh) | 用于治疗t细胞耗竭的组合物和方法 | |
| CN108727470A (zh) | 一种多肽及其应用 |